Sociodemographic and Clinical Predictors of Neoadjuvant Chemotherapy in cT1-T2/N0 HER2-Amplified Breast Cancer.

Emilie D DuchesneauSelena J AnPaula D StrassleKatherine E Reeder-HayesKristalyn K GallagherDavid W OllilaStephanie M Downs-CannerPhilip M Spanheimer

Published in: Annals of surgical oncology (2022)

Substantial differences in the utilization of neoadjuvant chemotherapy exist in women with HER2+ breast cancer, which reflect both clinical parameters and disparities. Optimal treatment strategies should be implemented equitably across sociodemographic groups.

Keyphrases

neoadjuvant chemotherapy
locally advanced
lymph node
sentinel lymph node
rectal cancer
squamous cell carcinoma
radiation therapy
magnetic resonance imaging
contrast enhanced
pet ct